Most cancer cell therapies have employed transfusion of autologous T-cells into patients, including CD8+ CTLs alone or combined with CD4+ helper (Th) cells, although NK or cytokine-induced killer cells and macrophages have also been used [320,321]. Here, CD8A is linked to cancer.